a public good project by the
Synthesis
Company
of California

© 2026

Craig LaForce | doi.page

0 works0 citations0 h-index

Craig LaForce

North Carolina Clinical Research(US)

Publications by Year

Research Areas

Asthma and respiratory diseases, Inhalation and Respiratory Drug Delivery, Respiratory and Cough-Related Research, Allergic Rhinitis and Sensitization, Chronic Obstructive Pulmonary Disease (COPD) Research

Most-Cited Works

→ Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial(2021)539 cited
→ A Comparison of Salmeterol with Albuterol in the Treatment of Mild-to-Moderate Asthma(1992)361 cited
→ Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis☆☆☆★★★(1997)326 cited
→ Effect of Vitamin D₃on Asthma Treatment Failures in Adults With Symptomatic Asthma and Lower Vitamin D Levels(2014)269 cited
→ Montelukast for treating seasonal allergic rhinitis: a randomized, double‐blind, placebo‐controlled trial performed in the spring(2002)242 cited
→ Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: A randomized, double-blind, placebo-controlled trial(2000)240 cited

→ Growth in asthmatic children treated with fluticasone propionate(1998)

172 cited

→ Safety profile and clinical activity of multiple subcutaneous doses of MEDI-528, a humanized anti-interleukin-9 monoclonal antibody, in two randomized phase 2a studies in subjects with asthma(2011)142 cited

→ Benralizumab for patients with mild to moderate, persistent asthma (BISE): a randomised, double-blind, placebo-controlled, phase 3 trial(2017)121 cited

→ Mometasone or Tiotropium in Mild Asthma with a Low Sputum Eosinophil Level(2019)121 cited